Subsequently, we proved that restoration of CD44 could rescue the antitumor effects of miR-34a by co-transfection of miR-34a mimics and CD44 in bladder cancer cell lines (Figure 4E and Figure 5B). The gene discussed is CD44; the disease is urinary bladder cancer.